Concepedia

Michelle Z. Dion

MZ

7

Publications

288

Citations

7

H-Index

2017

Active since

Affiliations

Massachusetts Institute of Technology(Current)

Harvard University

Brigham and Women's Hospital

Harvard–MIT Division of Health Sciences and Technology

Pharmaceutical Product Development (United States)

Michelle Z. Dion is an author at Massachusetts Institute of Technology specializing in medicine, pharmacology, and engineering.

ORCID

Top concepts

Publications per year

2017–2024

7

Publications

7

Investigation of the enhanced antitumour potency of STING agonist after conjugation to polymer nanoparticles

Pere Dosta, Alexander M. Cryer, Michelle Z. Dion et al. · Nature Nanotechnology · 2023 · 138 citations

, , +8

Mitigation of Oxidation in Therapeutic Antibody Formulations: a Biochemical Efficacy and Safety Evaluation of N-Acetyl-Tryptophan and L-Methionine

Michelle Z. Dion, Danielle L. Leiske, Vikas Sharma et al. · Pharmaceutical Research · 2018 · 36 citations

, , +6

Matrix Metalloproteinase- and pH-Sensitive Nanoparticle System Enhances Drug Retention and Penetration in Glioblastoma

Pere Dosta, Michelle Z. Dion, Michaela Prado et al. · ACS Nano · 2024 · 31 citations

, , +21

The Use of a 2,2'-Azobis (2-Amidinopropane) Dihydrochloride Stress Model as an Indicator of Oxidation Susceptibility for Monoclonal Antibodies

Michelle Z. Dion, Y. John Wang, Daniel T. Bregante et al. · Journal of Pharmaceutical Sciences · 2017 · 24 citations

, , +13

Delivery of Stimulator of Interferon Genes (STING) Agonist Using Polypeptide‐Modified Dendrimer Nanoparticles in the Treatment of Melanoma

Pere Dosta, Alexander M. Cryer, Michaela Prado et al. · Advanced NanoBiomed Research · 2021 · 21 citations · Full text

, , +27

Rows per page

1–5 of 7